Lisa Orloff, MD

Dr. Lisa Orloff’s work—understanding and expanding the role of ultrasound within the multidisciplinary management of endocrine head and neck disease—has transformed the manner in which patients with thyroid and parathyroid disorders are evaluated and cared for.


Dr. Orloff recently authored the second edition of her textbook, Head and Neck Ultrasonography (Plural Publishing), and she co-directs the national ACS Thyroid, Parathyroid, and Neck Ultrasound course, providing ultrasound education and refined diagnostic assessment and treatment planning for scores of head and neck and thyroid surgeons.

Lisa A. Orloff, MD, FACS, FACE is Professor and Director of Endocrine Head and Neck Surgery in the Department of Otolaryngology/Head and Neck Surgery, at Stanford University School of Medicine. She directs the Thyroid Tumor Program at the Stanford Cancer Center. Dr. Orloff earned her B.A. from Stanford University and her medical degree from the University of California, Los Angeles. She completed her internship and residency in Otolaryngology/Head and Neck Surgery at the University of Washington in Seattle, and received mentorship in Microvascular and Reconstructive Surgery by Dr. Mark Urken at the Mount Sinai Medical Center in New York. Prior to joining Stanford’s faculty in 2014, Dr. Orloff was the Robert K. Werbe Distinguished Professor in Head and Neck Cancer, and Chief of the Division of Head and Neck Surgery at the University of California, San Francisco, dedicating her practice to the care of patients with head and neck and thyroid cancer. She holds leadership roles within the American Head and Neck Society, the American Thyroid Association, and the American College of Surgeons, including serving as a member of the National Ultrasound Faculty and as Co-Chair of the Thyroid and Parathyroid Ultrasound Program. Dr. Orloff is the first surgeon ever to be accredited by the American Institute of Ultrasound in Medicine for expertise in head and neck ultrasonography. She is a former Fulbright scholar, and she has served as a voting member of the FDA’s Panel to evaluate medical devices for Otolaryngology. Dr. Orloff’s current clinical practice is focused on surgical management of thyroid and parathyroid tumors and recurrent, metastatic and invasive thyroid cancer.